P3 Health Partners Inc. Announces Executive Changes
Ticker: PIIIW · Form: 8-K · Filed: Aug 29, 2024 · CIK: 1832511
| Field | Detail |
|---|---|
| Company | P3 Health Partners Inc. (PIIIW) |
| Form Type | 8-K |
| Filed Date | Aug 29, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0001, $11.50, $440,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, officer-appointment, director-departure
TL;DR
P3 Health Partners Inc. swapped a director and named a new CMO, with executive pay details also disclosed.
AI Summary
On August 29, 2024, P3 Health Partners Inc. filed an 8-K detailing the departure of Director Dr. Michael L. Riff and the appointment of Dr. David M. Smith as Chief Medical Officer. The filing also addresses compensatory arrangements for certain officers.
Why It Matters
Changes in key leadership roles and executive compensation can signal shifts in company strategy or financial health, impacting investor confidence.
Risk Assessment
Risk Level: medium — Executive changes and compensation disclosures can sometimes precede or indicate underlying business challenges or strategic shifts.
Key Players & Entities
- P3 Health Partners Inc. (company) — Registrant
- Dr. Michael L. Riff (person) — Departing Director
- Dr. David M. Smith (person) — Appointed Chief Medical Officer
- August 29, 2024 (date) — Date of Report
FAQ
Who has departed from the board of directors at P3 Health Partners Inc.?
Dr. Michael L. Riff has departed from the board of directors.
Who has been appointed as the new Chief Medical Officer?
Dr. David M. Smith has been appointed as the new Chief Medical Officer.
What is the exact date of this 8-K filing?
The exact date of this 8-K filing is August 29, 2024.
What is the principal executive office address for P3 Health Partners Inc.?
The principal executive office address is 2370 Corporate Circle Suite 300 Henderson, Nevada 89074.
What other items are covered in this 8-K filing besides director departure and officer appointment?
This 8-K filing also covers the election of directors and compensatory arrangements of certain officers.
Filing Stats: 1,400 words · 6 min read · ~5 pages · Grade level 12.1 · Accepted 2024-08-29 16:05:55
Key Financial Figures
- $0.0001 — stered Class A common stock, par value $0.0001 per share PIII The Nasdaq Stock Market
- $11.50 — A common stock at an exercise price of $11.50 PIIIW The Nasdaq Stock Market LLC Ind
- $440,000 — w. The Offer Letter provides for (i) a $440,000 annual base salary and (ii) eligibility
Filing Documents
- piii-20240829.htm (8-K) — 33KB
- piii-20240829_g1.jpg (GRAPHIC) — 201KB
- 0001628280-24-038802.txt ( ) — 663KB
- piii-20240829.xsd (EX-101.SCH) — 2KB
- piii-20240829_def.xml (EX-101.DEF) — 15KB
- piii-20240829_lab.xml (EX-101.LAB) — 26KB
- piii-20240829_pre.xml (EX-101.PRE) — 16KB
- piii-20240829_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. P3 Health Partners Inc. Date: August 29, 2024 By: /s/ Aric Coffman, M.D. Aric Coffman, M.D. Chief Executive Officer